Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
232
Views
0
CrossRef citations to date
0
Altmetric
Gastroenterology

Plecanatide Improves Symptoms of Irritable Bowel Syndrome with Constipation: Results of an Integrated Efficacy and Safety Analysis of Two Phase 3 Trials

Darren M Brenner1 Internal Medicine-Gastroenterology, Northwestern University-Feinberg School of Medicine, Chicago, IL, USACorrespondence[email protected]
View further author information
,
Spencer D Dorn2 Division of Gastroenterology and Hepatology, UNC School of Medicine, Chapel Hill, NC, USAView further author information
,
Ronald P Fogel3 Digestive Health Center of Michigan, Chesterfield, MI, USAView further author information
,
Jennifer Christie4 Emory University School of Medicine, Atlanta, GA, USAView further author information
,
Adam P Laitman5 Salix Pharmaceuticals, Bridgewater, NJ, USAView further author information
&
Jonathan Rosenberg6 GI Alliance of Illinois, Gurnee, IL, USAView further author information
Pages 3769-3777 | Received 21 Mar 2023, Accepted 07 Aug 2023, Published online: 25 Aug 2023

References

  • Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393–1407. doi:10.1053/j.gastro.2016.02.031
  • Shah ED, Almario CV, Spiegel BM, Chey WD. Presentation and characteristics of abdominal pain vary by irritable bowel syndrome subtype: results of a nationwide population-based study. Am J Gastroenterol. 2020;115(2):294–301. doi:10.14309/ajg.0000000000000502
  • Lacy BE, Cangemi D, Vazquez-Roque M. Management of chronic abdominal distension and bloating. Clin Gastroenterol Hepatol. 2021;19(2):219–231. doi:10.1016/j.cgh.2020.03.056
  • Taylor DCA, Abel JL, Martin C, et al. Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR). J Med Econ. 2020;23(10):1072–1083. doi:10.1080/13696998.2020.1799816
  • Ballou S, McMahon C, Lee HN, et al. Effects of irritable bowel syndrome on daily activities vary among subtypes based on results from the IBS in America survey. Clin Gastroenterol Hepatol. 2019;17(12):2471–2478. doi:10.1016/j.cgh.2019.08.016
  • Paré P, Gray J, Lam S, et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther. 2006;28(10):1726–1735. doi:10.1016/j.clinthera.2006.10.010
  • Doshi JA, Cai Q, Buono JL, et al. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population. J Manag Care Pharm. 2014;20(4):382–390. doi:10.18553/jmcp.2014.20.4.382
  • Nellesen D, Yee K, Chawla A, Edelman Lewis B, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manage Care Pharm. 2013;19(9):755–764. doi:10.18553/jmcp.2013.19.9.755
  • Brenner DM, Lacy BE, Ford AC, et al. Linaclotide reduced response time for irritable bowel syndrome with constipation symptoms: analysis of 4 randomized controlled trials. Am J Gastroenterol. 2023;118(5):872–879. doi:10.14309/ajg.0000000000002064
  • Salix Pharmaceuticals. Trulance tablets, for oral use [package insert]. Salix Pharmaceuticals, Bridgewater, NJ; 2021.
  • Brenner DM, Fogel R, Dorn SD, et al. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials. Am J Gastroenterol. 2018;113(5):735–745. doi:10.1038/s41395-018-0026-7
  • Oh SJ, Fuller G, Patel D, et al. Chronic constipation in the United States: results from a population-based survey assessing healthcare seeking and use of pharmacotherapy. Am J Gastroenterol. 2020;115(6):895–905. doi:10.14309/ajg.0000000000000614
  • Quigley EMM, Horn J, Kissous-Hunt M, Crozier RA, Harris LA. Better understanding and recognition of the disconnects, experiences, and needs of patients with irritable bowel syndrome with constipation (BURDEN IBS-C) study: results of an online questionnaire. Adv Ther. 2018;35(7):967–980. doi:10.1007/s12325-018-0733-x
  • Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17–44. doi:10.14309/ajg.0000000000001036
  • Awad RA, Camacho S. A randomized, double-blind, placebo-controlled trial of polyethylene glycol effects on fasting and postprandial rectal sensitivity and symptoms in hypersensitive constipation-predominant irritable bowel syndrome. Colorectal Dis. 2010;12(11):1131–1138. doi:10.1111/j.1463-1318.2009.01990.x
  • Chapman RW, Stanghellini V, Geraint M, Halphen M. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol. 2013;108(9):1508–1515. doi:10.1038/ajg.2013.197
  • Oh JE, Chey WD, Spiegel B. Abdominal bloating in the US: results of a survey of 88,795 Americans examining prevalence and healthcare seeking. Clin Gastroenterol Hepatol. 2022;21:2370–2377. doi:10.1016/j.cgh.2022.10.031

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.